SCOPE OF THE REPORT
Hepatitis Testing/Diagnosis Market Overview
The global hepatitis testing/diagnosis market is expected to grow at a 5 % CAGR from 2022 to 2029. It is expected to reach above USD 4.14 billion by 2029 from USD 2.66 billion in 2020.
Hepatitis is a broad term that refers to liver inflammation. Hepatitis can be caused by excessive alcohol consumption, some drugs, pollutants, and certain medical problems. Hepatitis, on the other hand, is frequently caused by viral infection. Hepatitis A, hepatitis B, and hepatitis C are the three most frequent kinds of viral hepatitis. In low- and middle-income nations, the burden of HBV and HCV is disproportionately high. The majority of the worldwide population with chronic HBV infection were infected when they were born or in early childhood, and perinatal or horizontal transmission was common. The high burden of hepatitis, increased blood transfusions and donations, the benefits of POC devices and kits, and hepatitis awareness programs are all driving the worldwide hepatitis testing market forward.
ATTRIBUTE | DETAILS |
Study period | 2020-2029 |
Base year | 2021 |
Estimated year | 2022 |
Forecasted year | 2022-2029 |
Historical period | 2018-2020 |
Unit | Value (USD Million) |
Segmentation | By Disease Type, By Technology, By End-User |
By Disease Type |
|
By Technology |
|
By End-user |
|
By Region |
|
Due to fewer patient visits to hospitals, the COVID-19 outbreak had a detrimental influence on the hepatitis testing business. Healthcare systems have been severely strained as a result of the pandemic. To prevent the spread of the disease and conserve healthcare resources for COVID-19 patients, healthcare institutes and providers were told to halt performing elective surgical operations and medical evaluations. As a result, the volume of testing at many hepatitis testing clinical laboratories has dropped dramatically.
Rising consumer awareness of the benefits of hepatitis virus testing in determining the best course of treatment and prevention, as well as changing lifestyle and food consumption habits, rising medication side effects, excessive alcohol consumption, rising incidence of viral hepatitis and autoimmune diseases, rising disposable income of consumers, rising medical tourism, and the rising presence of large demography of hepatitis patients are all driving market growth. Furthermore, rising technological advancements and modernization in the healthcare sector, rising healthcare research and development activities, and rising emerging markets with an increasing geriatric population base will all create new opportunities for the hepatitis test solution/diagnosis market in the forecasted period.
Hepatitis market expansion is likely to be hampered by the high cost of nucleic acid testing, a lack of mandates for nucleic acid tests in emerging countries, and poor reimbursement situations. Emerging markets, rising technical breakthroughs in molecular diagnostics, and growth in the biotechnology and biopharmaceutical industries are likely to provide the market with significant potential possibilities. Changing regulatory landscapes, operational hurdles, and a scarcity of skilled personnel, on the other hand, may provide some challenges to market expansion.
Hepatitis Testing/Diagnosis Market Segment Analysis
On the basis of disease type, the market is segmented into Hepatitis B, Hepatitis C, Other Hepatitis. Based on technology, the hepatitis testing/diagnosis market is bifurcated into ELISA, RDT, PCR, INAAT. On the basis of the end-user, the market is segmented into Hospitals, Diagnostic Laboratories, Blood Banks.
The hepatitis B segment accounted for the largest share of the hepatitis testing market. Â The rising prevalence of hepatitis B, the availability of a large variety of hepatitis B diagnostic tests, and the growing use of nucleic acid tests for HBV diagnosis are all driving this market segment’s rise.
The ELISA segment accounted for the largest share of the hepatitis testing market in 2020. The extensive use of this test in clinical procedures to identify hepatitis is principally responsible for the substantial proportion of this category. Immunoassays are bioanalytical procedures that rely on the reaction of an antigen and an antibody to determine the concentration of an analyte. Immunoassays have been shown to offer very accurate results even with very little samples when compared to conventional testing. Immunoassay has become increasingly popular in recent years due to its wide range of applications and ease of diagnosis. In addition, with the rise in hepatitis cases, the market is likely to grow.
The hospital & diagnostic laboratories segment accounted for the largest share of the hepatitis testing market. The large share of this segment can be attributed to the large number of hepatitis diagnostic tests carried out in hospitals.
Hepatitis Testing/Diagnosis Market Players
The major players covered in the hepatitis test solution/diagnosis market are F. Hoffmann-La Roche Ltd, Abbott, Bio-Rad Laboratories Inc., Siemens, DiaSorin, QIAGEN, Danaher, bioMérieux SA, Grifols S.A., Ortho Clinical Diagnostics, FUJIREBIO Inc and Others.
These companies have adopted various organic as well as inorganic growth strategies to strengthen their position in the market. New product development, merger & acquisition, and expansion were among the key growth strategies adopted by these leading players to enhance their product offering and regional presence and meet the growing demand for hepatitis testing/diagnosis in the emerging economies.
Recent Developments Â
- In 2021, Abbott received FDA Emergency Use Authorization (EUA) for the Alinity m Resp-4-Plex assay.
- In 2021, F. Hoffmann-La Roche Ltd. acquired GenMark Diagnostics (US) which aimed at adding more products to Roche’s molecular diagnostics portfolio and the global distribution of products offered by GenMark Diagnostics.
- In 2021, Bio-Rad Laboratories, Inc. partnered with Seegene, Inc. (South Korea). The partnership aims at collaborative development and the commercialization of infectious disease diagnostic
Who Should Buy? Or Key Stakeholders
- Hepatitis testing/diagnosis suppliers
- Investors
- Research institutes
- Medical Institutes
- Environment, Health and Safety Professionals
Hepatitis Testing/Diagnosis Market Regional Analysis
The global hepatitis testing/diagnosis market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
North America dominates the global market, and this trend is expected to continue during the forecast period. The rising prevalence of hepatitis, as well as increased research and clinical trials for hepatitis testing in the United States, are the reason for this region’s growth.
Key Market Segments: Global Hepatitis Testing/Diagnosis Market
Global Hepatitis Testing/Diagnosis Market by Disease Type, 2020-2029, (USD Million)
- Hepatitis B
- Hepatitis C
- Other Hepatitis
Global Hepatitis Testing/Diagnosis Market by Technology, 2020-2029, (USD Million)
- Elisa
- RDT
- PCR
- INAAT
Global Hepatitis Testing/Diagnosis Market by End-User, 2020-2029, (USD Million)
- Hospitals
- Diagnostic Laboratories
- Blood Banks
Global Hepatitis Testing/Diagnosis Market by Region, 2020-2029, (USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East And Africa
Important countries in all regions are covered.
Key Question Answered
- What are the growth opportunities related to the adoption of the hepatitis testing/diagnosis market across major regions in the future?
- What are the new trends and advancements in the hepatitis testing/diagnosis market?
- Which product categories are expected to have the highest growth rate in the hepatitis testing/diagnosis market?
- Which are the key factors driving the hepatitis testing/diagnosis market?
- What will the hepatitis testing/diagnosis market growth rate, growth momentum, or acceleration the market carries during the forecast period?
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global Hepatitis Testing/Diagnosis Market Outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 On Global Hepatitis Testing/Diagnosis Market
- Global Hepatitis Testing/Diagnosis Market Outlook
- Global Hepatitis Testing/Diagnosis Market by Disease Type, (USD Million)
- Hepatitis B
- Hepatitis C
- Other Hepatitis
- Global Hepatitis Testing/Diagnosis Market by Technology, (USD Million)
- ELISA
- RDT
- PCR
- INAAT
- Global Hepatitis Testing/Diagnosis Market by End-User, (USD Million)
- Hospitals
- Diagnostic Laboratories
- Blood Banks
- Global Hepatitis Testing/Diagnosis Market by Region, (USD Million)
- Introduction
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- South-East Asia
- Rest of Asia-Pacific
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Rest of Europe
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Middle- East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle- East and Africa
- Company Profiles* (Business Overview, Company Snapshot, PRODUCT TYPEs Offered, Recent De velopments)
-
- Hoffmann-La Roche Ltd
- Abbott
- Siemens
- DiaSorin
- QIAGEN
- Danaher
- bioMérieux SA
- Grifols S.A
- Ortho Clinical Diagnostics
- FUJIREBIO Inc
*The Company List Is Indicative
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL HEPATITIS TESTING/DIAGNOSIS MARKET BY REGION (USD MILLIONS), 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA HEPATITIS TESTING/DIAGNOSIS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â US HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â US HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (MILLIONS), 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA HEPATITIS TESTING/DIAGNOSIS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC HEPATITIS TESTING/DIAGNOSIS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH EAST ASIA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE HEPATITIS TESTING/DIAGNOSIS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â UK HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â UK HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â UK HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 80Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 81Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 82Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 83Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 84Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA HEPATITIS TESTING/DIAGNOSIS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 85Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 86Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 87Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 88Â Â Â Â Â Â Â Â Â Â Â Â Â UAE HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 89Â Â Â Â Â Â Â Â Â Â Â Â Â UAE HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 90Â Â Â Â Â Â Â Â Â Â Â Â Â UAE HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 91Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 92Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 93Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 94Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 95Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 96Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
TABLE 97Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 98Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 99Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER (USD MILLIONS), 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE, USD MILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY, USD MILLION, 2020-2029
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER, USD MILLION, 2020-2029
FIGURE 11Â Â Â Â Â Â Â Â Â Â GLOBAL HEPATITIS TESTING/DIAGNOSIS MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 12          PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â Â Â Â Â Â Â Â GLOBAL HEPATITIS TESTING/DIAGNOSIS MARKET BY DISEASE TYPE, USD MILLION, 2020-2029
FIGURE 14Â Â Â Â Â Â Â Â Â Â GLOBAL HEPATITIS TESTING/DIAGNOSIS MARKET BY TECHNOLOGY, USD MILLION, 2020-2029
FIGURE 15Â Â Â Â Â Â Â Â Â Â GLOBAL HEPATITIS TESTING/DIAGNOSIS MARKET BY END-USER, USD MILLION, 2020-2029
FIGURE 16Â Â Â Â Â Â Â Â Â Â GLOBAL HEPATITIS TESTING/DIAGNOSIS MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 17Â Â Â Â Â Â Â Â Â Â HEPATITIS TESTING/DIAGNOSIS MARKET BY REGION 2021
FIGURE 18Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 19Â Â Â Â Â Â Â Â Â Â F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â Â Â Â ABBOTT: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â SIEMENS: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â DIASORIN: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â QIAGEN: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â DANAHER: COMPANY SNAPSHOT
FIGURE 26          BIOMÉRIEUX SA: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â GRIFOLS S.A: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â Â Â Â Â ORTHO CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT
FIGURE 29Â Â Â Â Â Â Â Â Â Â FUJIREBIO INC: COMPANY SNAPSHOT
FAQ
The hepatitis testing/diagnosis market size had crossed USD 2.66 Billion in 2020 and will observe a CAGR of 5% up to 2029 driven by the high burden of hepatitis, increased blood transfusions and donations, the benefits of POC devices and kits, and hepatitis awareness programs
North America held more than 35% of the hepatitis testing/diagnosis market revenue share in 2020 and will witness expansion with the rising prevalence of hepatitis, as well as increased research and clinical trials for hepatitis testing
The upcoming trends in the hepatitis testing/diagnosis market are rising consumer awareness.
The global hepatitis testing/diagnosis market registered a CAGR of 5 % from 2022 to 2029. The hepatitis B segment was the highest revenue contributor to the market.
It is used to test/ diagnose the hepatitis virus.
North America is the largest regional market for hepatitis testing/diagnosis market
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.